🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cardiotoxicity

Effects of Exercise Training in Survivors of Lymphoma NCT06270667NA2 sites📍 Oslo📍 Uppsala Norwegian School of Sport Sciences · Tests: Aerobic Exercise, Combined Aerobic and Resistance Exercise Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients NCT07233499Phase 21 site📍 Cairo Ain Shams University · Tests: Nebivolol 5 mg JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors NCT04294771n/a1 site📍 Paris Groupe Hospitalier Pitie-Salpetriere · Tests: ICI CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL NCT06304857Phase 33 sites📍 Wroclaw📍 Wroclaw📍 Warsaw 4th Military Clinical Hospital with Polyclinic, Poland · Tests: Dapagliflozin, Placebo Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity. NCT07663357n/a6 sites📍 Fortaleza📍 Recife📍 Florianópolis Beneficência Portuguesa de São Paulo JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year NCT06930521NA1 site📍 Toronto Women's College Hospital · Tests: Intervention - Low Risk Group OR Intermediate Risk Group Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity NCT06427226Phase 21 site📍 Alexandria Tanta University · Tests: Dapagliflozin 10mg Tab Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy NCT06282796n/a5 sites📍 Fuzhou📍 Dalian📍 Dalian First Hospital of China Medical University · Tests: Echocardiography AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor NCT06699056n/a8 sites📍 Orange📍 Pasadena📍 Detroit Peerbridge Health, Inc · Tests: 15-minutes of sitting during COR ECG Acquistion Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study NCT06595147NA1 site📍 Edmonton University of Alberta · Tests: Structured Exercise Training, Group-based Yoga and Stretching NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients NCT06845319Phase 21 site📍 Charleston Medical University of South Carolina · Tests: Carboplatin, Paclitaxel, Pembrolizumab RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer NCT05256745Phase 1, Phase 23 sites📍 Washington D.C.📍 Washington D.C.📍 Hackensack Georgetown University · Tests: TTP488, ddAC/ddT, TC, TCHP, Chemotherapy regimen that includes ddAC Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction NCT03934905Phase 1, Phase 21 site📍 Lubbock Texas Tech University Health Sciences Center · Tests: sulforaphane, Placebo Oral Tablet Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure NCT04262830n/a1 site📍 San Diego Hari Narayan · Tests: Cardiac magnetic resonance imaging (MRI), Accelerometer physical activity monitoring Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer NCT06781762n/a1 site📍 Toronto University of Toronto · Tests: N/A (Usual Care) PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity NCT07070765NA2 sites📍 Aberdeen📍 Aberdeen University of Aberdeen · Tests: Sodium-glucose transport-2 (SGLT-2) inhibitors, Standard medical treatment Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study NCT05851053n/a1 site📍 Groningen University Medical Center Groningen · Tests: Echocardiography Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines NCT06774326n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial) NCT03711110NA14 sites📍 Santiago de Compostela📍 Galdakao📍 Barcelona Fundación Instituto de Estudios de Ciencias de la Salud de … · Tests: Intensive cardiovascular monitoring, No intervention COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) NCT05258448n/a1 site📍 Odense C Odense University Hospital · Tests: Chemoradiotherapy Early Assessment of Cardiac Function After Treatment With CAR-T Cells NCT06350994n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer NCT07588425n/a1 site📍 Ankara Fatih GURLER REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs NCT05223413NA24 sites📍 Aarhus📍 Montivilliers📍 Rouen Fundación Centro Nacional de Investigaciones Cardiovascular… · Tests: RIPC, Simulated RIPC (Sham) Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care NCT03882580n/a3 sites📍 Paris📍 Paris📍 Paris Groupe Hospitalier Pitie-Salpetriere · Tests: Anti-Cancer Agents The STOP-MED CTRCD Trial NCT06183437Phase 414 sites📍 Los Angeles📍 Boston📍 Melbourne Dinesh Thavendiranathan · Tests: Stopping Heart Failure Medication(s) Heart Failure in Women: Epidemiological and Prognostic Insights NCT07847983n/a24 sites📍 A Coruña📍 Santiago de Compostela📍 Badajoz Carolina Ortiz Cortes The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity NCT06214195Phase 31 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis) Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy NCT07528586NA1 site📍 Stuttgart Robert Bosch Gesellschaft für Medizinische Forschung mbH (R… · Tests: CMR based measurement of cardiotoxicity, biosampling for scientific research in study-specific biobank Global Cardio Oncology Registry NCT05598879n/a1 site📍 Weston The Cleveland Clinic · Tests: anonymized data collection during programmed surveillance clinical follow up
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy